To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

NCT05889325 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Liver Metastases (CRCLM)

Interventions

PROCEDURE: DEB-TACE plus HAIC

Sponsor

Peking University Cancer Hospital & Institute